Tris-CAR-T Cell Therapy for Recurrent Glioblastoma
Tris-CAR-T Cell Therapy for Recurrent Glioblastoma
Recruiting · NCT05577091 · Registry updated 2024-04-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Tris-CAR-T Cell Therapy for Recurrent Glioblastoma | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), epithelial neoplasm, glioblastoma, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Recruiting | Phase 1 | 2024-04-12 | NCT05577091 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Beijing Neurosurgical Institute | 9 |
| Beijing Tiantan Hospital | 307 |
| Tasly Pharmaceutical Group Co., Ltd | 16 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing Tiantan Hospital | Beijing | China | 62 |